Crossmark

Intensive Care Unit Admission for Patients in the INTERACT2 ICH Blood Pressure Treatment Trial: Characteristics, Predictors, and Outcomes

Crossref DOI link: https://doi.org/10.1007/s12028-016-0365-4

Published Online: 2016-12-20

Published Print: 2017-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Wartenberg, Katja E.

Wang, Xia

Muñoz-Venturelli, Paula

Rabinstein, Alejandro A.

Lavados, Pablo M.

Anderson, Craig S.

Robinson, Thompson
Funding

Funding for this research was provided by:

National Health and Medical Research Council of Australia (Program Grant 571281)

National Health and Medical Research Council of Australia (Project Grant 512402)

National Health and Medical Research Council of Australia (Project Grant 1004170)
License Information

License valid from 2016-12-20